Growth Metrics

Metagenomi (MGX) Share-based Compensation (2023 - 2025)

Historic Share-based Compensation for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $3.0 million.

  • Metagenomi's Share-based Compensation fell 660.87% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year decrease of 1762.66%. This contributed to the annual value of $16.2 million for FY2024, which is 13409.42% up from last year.
  • According to the latest figures from Q3 2025, Metagenomi's Share-based Compensation is $3.0 million, which was down 660.87% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, Metagenomi's Share-based Compensation ranged from a high of $5.1 million in Q1 2024 and a low of $529000.0 during Q1 2023
  • For the 3-year period, Metagenomi's Share-based Compensation averaged around $2.9 million, with its median value being $3.2 million (2025).
  • As far as peak fluctuations go, Metagenomi's Share-based Compensation surged by 85595.46% in 2024, and later tumbled by 4210.01% in 2025.
  • Quarter analysis of 3 years shows Metagenomi's Share-based Compensation stood at $2.5 million in 2023, then soared by 38.19% to $3.4 million in 2024, then dropped by 11.78% to $3.0 million in 2025.
  • Its Share-based Compensation was $3.0 million in Q3 2025, compared to $3.2 million in Q2 2025 and $2.9 million in Q1 2025.